Skip to main
AVNT
AVNT logo

Avient Corp (AVNT) Stock Forecast & Price Target

Avient Corp (AVNT) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Avient Corp reports a positive financial outlook, underscored by a 5% increase in organic sales, driven significantly by robust growth in the healthcare sector, which experienced a 14% year-over-year increase in the first half of 2025. Additionally, four of the nine end markets, representing 40% of the company's sales, are currently showing growth, contributing to an overall organic sales rise of approximately 2% expected for 2025. Despite anticipated challenges in the consumer end market in the latter half of 2025, the diversified product portfolio and strong performance in key sectors suggest a resilient business model.

Bears say

Avient Corp has experienced a decline in organic sales, with a notable 2% drop in the first quarter of 2024, despite some recovery indications in subsequent quarters. The outlook for demand in the chemicals sector has been negative, with signs of weakening volume anticipated in the second half of 2025, raising concerns about future revenue stability. Additionally, while a declining dollar could provide a temporary boost, the underlying demand challenges in key segments may overshadow any potential benefits from currency fluctuations.

Avient Corp (AVNT) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Avient Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Avient Corp (AVNT) Forecast

Analysts have given Avient Corp (AVNT) a Buy based on their latest research and market trends.

According to 6 analysts, Avient Corp (AVNT) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $45.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $45.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Avient Corp (AVNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.